The Patent Finder

Pacific Edge Limited

Also on record
Records under this name other than the patents Pacific Edge Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Pacific Edge Limited

PatentTitleStatus Expires Confidence
US 8,822,149Prognosis Prediction for Melanoma Cancer
Lapsed on the fee record
Ended Sep 2, 2026 · High confidence
Lapsed on the fee recordEnded Sep 2, 2026High confidence
US 10,024,859Markers for Detection of Gastric Cancer
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 9,982,305Polymerase Chain Reaction Test Kits for Detecting Markers of Bladder Cancer
Lapsed on the fee record
Ended May 29, 2026 · High confidence
Lapsed on the fee recordEnded May 29, 2026High confidence
US 11,208,698Methods for Detection of Markers Bladder Cancer and Inflammatory Conditions of the Bladder and Treatment Thereof
Lapsed on the fee record
Ended Dec 28, 2025 · High confidence
Lapsed on the fee recordEnded Dec 28, 2025High confidence
US 11,180,815Methods for treating colorectal cancer using prognostic genetic markers
Lapsed on the fee record
Ended Nov 23, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 23, 2025From the USPTO record
US 9,809,860Test Kits and Methods for Their Use in Detecting Expression Ratios of Genetic Markers
Lapsed on the fee record
Ended Nov 7, 2025 · Medium confidence
Lapsed on the fee recordEnded Nov 7, 2025Medium confidence
US 11,130,789Urine markers for detection of bladder cancer
Lapsed on the fee record
Ended Sep 28, 2025 · High confidence
Lapsed on the fee recordEnded Sep 28, 2025High confidence
US 9,702,009Urine Gene Expression Ratios for Detection of Cancer
Lapsed on the fee record
Ended Jul 11, 2025 · Medium confidence
Lapsed on the fee recordEnded Jul 11, 2025Medium confidence
US 9,534,258Devices and Methods for Prognosis Prediction for Melanoma Cancer
Formerly held
Lapsed on the fee record
Ended Jan 3, 2025 · High confidence
Lapsed on the fee recordEnded Jan 3, 2025High confidence
US 10,689,707Treatment of recurrent gastric cancer identified using genetic biomarkers
Lapsed on the fee record
Ended Jun 23, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 23, 2024From the USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited